にきび治療の市場規模、シェア、成長分析：製品別、投与経路別、年齢層別、流通チャネル別、地域別 - 産業予測 2025～2032年

にきび治療の市場規模は2023年に116億2,000万米ドルと評価され、2024年の122億1,000万米ドルから2032年には181億8,000万米ドルに成長し、予測期間（2025-2032年）のCAGRは5.1％で成長する見通しです。

世界のにきび治療市場は、尋常性ざ瘡（世界人口の約9.4％が罹患する疾患）の有病率の増加、特に青少年の間で、大きな成長が見込まれています。この動向の要因としては、座りがちなライフスタイルの増加、食生活の乱れ、侵襲性の低い美容治療への嗜好の高まりなどが挙げられます。米国だけでも、年間5,000万人がこの皮膚疾患に直面しており、男性の90％、女性の80％が人生のどこかでニキビを経験しています。しかし、抗生物質やレチノイドなど、治療に使用される薬剤に関する安全性への懸念が、市場拡大の課題となっています。こうした懸念に対処しつつ、高まる需要を取り込むことが、今後の市場関係者にとって極めて重要になると思われます。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次データと一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• ケーススタディ
• 規制情勢
• 顧客と購買基準の分析
• スタートアップ分析
• 特許分析

にきび治療市場規模：製品別& CAGR（2025-2032）

• 市場概要
• レチノイド
• 抗生物質
• イソトレチノイン
• その他

にきび治療市場規模：投与経路別& CAGR（2025-2032）

• 市場概要
• 経口
• 局所

にきび治療市場規模：年齢層別& CAGR（2025-2032）

• 市場概要
• 10歳から17歳
• 18歳から44歳
• 45歳から64歳
• 65歳以上

にきび治療市場規模：流通チャネル別& CAGR（2025-2032）

• 市場概要
• 病院薬局
• 小売薬局
• オンライン薬局

にきび治療市場規模：地域別& CAGR（2025-2032）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 市場の最近の動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 会社概要
  • 製品ポートフォリオ分析
  • セグメント別シェア分析
  • 収益の前年比比較（2022-2024）

主要企業プロファイル

• Ortho Dermatologics（Bausch Health Companies Inc.）（USA）
• GSK plc（UK）
• Bayer AG（Germany）
• Johnson & Johnson Services, Inc.（USA）
• Pfizer Inc.（USA）
• AbbVie Inc.（USA）
• Teva Pharmaceutical Industries Ltd.（Israel）
• Botanix Pharmaceuticals（Australia）
• L'Oreal S.A.（France）
• Clinique Laboratories, LLC（USA）
• Neutrogena（USA）
• Ancalima Lifesciences Ltd.（India）
• Guthy-Renker（USA）
• Murad, Inc.（USA）
• Kose Corporation（Japan）
• Nestle Skin Health（Switzerland）
• Sun Pharmaceutical Industries Ltd.（India）
• Mylan N.V.（USA）

結論と推奨事項

Acne Treatment Market size was valued at USD 11.62 billion in 2023 and is poised to grow from USD 12.21 billion in 2024 to USD 18.18 billion by 2032, growing at a CAGR of 5.1% during the forecast period (2025-2032).

The global acne treatment market is poised for significant growth, driven by the increasing prevalence of acne vulgaris-a condition that affects approximately 9.4% of the global population, particularly among adolescents. Factors contributing to this trend include a rise in sedentary lifestyles, poor dietary habits, and a growing preference for less invasive cosmetic treatments. In the U.S. alone, 50 million individuals face this skin condition annually, with 90% of men and 80% of women experiencing acne at some point in their lives. However, the market's expansion is challenged by safety concerns regarding the medications used in treatment, including antibiotics and retinoids. Addressing these concerns while capitalizing on the rising demand will be crucial for market stakeholders moving forward.

Top-down and bottom-up approaches were used to estimate and validate the size of the Acne Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Acne Treatment Market Segments Analysis

Global Acne Treatment Market is segmented by Product, Route of Administration, Age Group, Distribution Channel and region. Based on Product, the market is segmented into Retinoids, Antibiotics, Isotretinoin and Others. Based on Route of Administration, the market is segmented into Oral and Topical. Based on Age Group, the market is segmented into 10 to 17 Years, 18 to 44 Years, 45 to 64 Years and 65 Years & Above. Based on Distribution Channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies and Online Pharmacies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Acne Treatment Market

The global acne treatment market is experiencing significant growth due to the increasing prevalence of skin disorders worldwide. This rise in cases is prompting more patients in regions such as North America, Europe, and Asia Pacific to seek treatment options. Additionally, the emergence of a variety of acne therapies, including retinoids, isotretinoin, and both oral and topical antibiotics, is contributing to heightened awareness of available products and treatments. As patients become more informed about their options, this growing awareness is anticipated to further propel the market's expansion, highlighting the need for effective acne treatments across different demographics.

Restraints in the Acne Treatment Market

The acne treatment market faces several challenges that hinder its growth, despite the widespread occurrence of chronic acne. Notably, a report from the National Center for Biotechnology Information (NCBI) highlights that common side effects associated with antibiotics, such as nausea, vomiting, and diarrhea, affect approximately 7% of patients using tetracyclines and 4% of those on macrolides. Additionally, the U.S. Food and Drug Administration (FDA) has raised concerns about certain over-the-counter (OTC) medications due to their potential to cause severe allergic reactions or significant irritation, further complicating the landscape for effective acne treatment options.

Market Trends of the Acne Treatment Market

The acne treatment market is experiencing a significant shift towards minimally invasive therapies as patient preferences evolve and technological advancements continue. Globally, there is a growing demand for less invasive cosmetic treatments, leading dermatologists to prioritize topical agents and combination therapies over traditional surgical options. Enhanced patient-physician communication and informed decision-making have fueled this trend, as individuals seek effective and less painful solutions for acne management. The rising availability of innovative treatment modalities-paired with improved procedural documentation-further drives the market, positioning minimally invasive techniques as the preferred choice for those seeking effective and convenient acne care.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape
• Customer & Buying Criteria Analysis
• Startup Analysis
• Patent Analysis

Global Acne Treatment Market Size by Product & CAGR (2025-2032)

• Market Overview
• Retinoids
• Antibiotics
• Isotretinoin
• Others

Global Acne Treatment Market Size by Route of Administration & CAGR (2025-2032)

• Market Overview
• Oral
• Topical

Global Acne Treatment Market Size by Age Group & CAGR (2025-2032)

• Market Overview
• 10 to 17 Years
• 18 to 44 Years
• 45 to 64 Years
• 65 Years & Above

Global Acne Treatment Market Size by Distribution Channel & CAGR (2025-2032)

• Market Overview
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Global Acne Treatment Market Size & CAGR (2025-2032)

• North America (Product, Route of Administration, Age Group, Distribution Channel)
  • US
  • Canada
• Europe (Product, Route of Administration, Age Group, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Route of Administration, Age Group, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Route of Administration, Age Group, Distribution Channel)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Route of Administration, Age Group, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Ortho Dermatologics (Bausch Health Companies Inc.) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GSK plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson Services, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AbbVie Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceutical Industries Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Botanix Pharmaceuticals (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• L'Oreal S.A. (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Clinique Laboratories, LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neutrogena (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ancalima Lifesciences Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Guthy-Renker (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Murad, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kose Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nestle Skin Health (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sun Pharmaceutical Industries Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mylan N.V. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations